인공 장기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Artificial Organs Market size is expected to reach USD 70.81 Billion in 2034 from USD 34.64 Billion (2025) growing at a CAGR of 8.27% during 2026-2034.

The global artificial organs market is expanding as medical technology advances to address the growing demand for organ replacement therapies. Artificial organs are medical devices designed to replicate the function of natural organs such as the heart, kidneys, and lungs. These devices are used to support patients who suffer from organ failure or severe chronic diseases.

Several factors are driving the growth of this market. The increasing prevalence of organ failure and the shortage of donor organs are creating strong demand for artificial organ technologies. Additionally, advancements in biomedical engineering and medical device manufacturing are improving the performance and safety of artificial organs.

The future prospects of the artificial organs market appear highly promising as research continues to improve device functionality and compatibility with the human body. Increasing investments in healthcare innovation and regenerative medicine may lead to the development of more advanced artificial organ systems. As medical technology progresses, artificial organs are expected to play an increasingly important role in life-saving treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Organ Type

• Artificial Heart
• Prosthetic Heart Valves
• Ventricular Assist Devices
• Cardiac Pacemakers
• Artificial Kidney
• Artificial Pancreas
• Artificial Lungs
• Cochlear Implants
• Artificial Liver
• Others

By Material Type

• Silicon
• Plastics
• Steel

By Type

• Permanent Artificial Organs
• Temporary Artificial Organs

COMPANIES PROFILED

• B Braun SE, Boston Scientific Corporation, Getinge AB, Abiomed, Asahi Kasei Corporation, Berlin Heart, Carmat, Jarvik Heart Inc, Terumo Corporation, SynCardia Systems LLC, Nipro Europe Group Companies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL ORGANS MARKET: BY ORGAN TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Organ Type
• 4.2. Artificial Heart Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prosthetic Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ventricular Assist Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cardiac Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Artificial Kidney Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Artificial Pancreas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Artificial Lungs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Cochlear Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Artificial Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL ORGANS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material Type
• 5.2. Silicon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plastics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Steel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL ORGANS MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Permanent Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Temporary Artificial Organs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTIFICIAL ORGANS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Organ Type
  • 7.2.2 By Material Type
  • 7.2.3 By Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Organ Type
  • 7.3.2 By Material Type
  • 7.3.3 By Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Organ Type
  • 7.4.2 By Material Type
  • 7.4.3 By Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Organ Type
  • 7.5.2 By Material Type
  • 7.5.3 By Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Organ Type
  • 7.6.2 By Material Type
  • 7.6.3 By Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTIFICIAL ORGANS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 B. Braun SE
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Getinge AB
  • 9.2.4 Abiomed
  • 9.2.5 Asahi Kasei Corporation
  • 9.2.6 Berlin Heart
  • 9.2.7 Carmat
  • 9.2.8 Jarvik Heart Inc
  • 9.2.9 Terumo Corporation
  • 9.2.10 SynCardia Systems LLC
  • 9.2.11 Nipro Europe Group Companies